Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 2	$ 185,364	$ (146,702)	$ 38,664
Balance (in shares) at Dec. 31, 2022	20,374,288
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		13		13
Exercise of stock options (in shares)	3,020
Issuance of common stock under stock incentive plans (in shares)	157,436
Stock-based compensation expense		1,160		1,160
Net Income (Loss)			761	761
Balance at Mar. 31, 2023	$ 2	186,537	(145,941)	40,598
Balance (in shares) at Mar. 31, 2023	20,534,744
Balance at Dec. 31, 2022	$ 2	185,364	(146,702)	38,664
Balance (in shares) at Dec. 31, 2022	20,374,288
Increase (Decrease) in Stockholders' Equity
Net Income (Loss)				7,084
Balance at Sep. 30, 2023	$ 2	189,974	(139,618)	50,358
Balance (in shares) at Sep. 30, 2023	20,934,919
Balance at Mar. 31, 2023	$ 2	186,537	(145,941)	40,598
Balance (in shares) at Mar. 31, 2023	20,534,744
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		148		148
Exercise of stock options (in shares)	36,353
Issuance of common stock under stock incentive plans		181		181
Issuance of common stock under stock incentive plans (in shares)	172,325
Stock-based compensation expense		1,260		1,260
Net Income (Loss)			3,885	3,885
Balance at Jun. 30, 2023	$ 2	188,126	(142,056)	46,072
Balance (in shares) at Jun. 30, 2023	20,743,422
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		566		566
Exercise of stock options (in shares)	103,697
Issuance of common stock under stock incentive plans (in shares)	87,564
Exercise of warrants		2		2
Exercise of warrants (in shares)	236
Stock-based compensation expense		1,280		1,280
Net Income (Loss)			2,438	2,438
Balance at Sep. 30, 2023	$ 2	189,974	(139,618)	50,358
Balance (in shares) at Sep. 30, 2023	20,934,919
Balance at Dec. 31, 2023	$ 2	191,569	(137,650)	53,921
Balance (in shares) at Dec. 31, 2023	21,080,472
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		353		353
Exercise of stock options (in shares)	96,116
Issuance of common stock under stock incentive plans (in shares)	229,923
Stock-based compensation expense		1,714		1,714
Net Income (Loss)			(202)	(202)
Balance at Mar. 31, 2024	$ 2	193,636	(137,852)	55,786
Balance (in shares) at Mar. 31, 2024	21,406,511
Balance at Dec. 31, 2023	$ 2	191,569	(137,650)	$ 53,921
Balance (in shares) at Dec. 31, 2023	21,080,472
Increase (Decrease) in Stockholders' Equity
Exercise of stock options (in shares)				116,842
Net Income (Loss)				$ (433)
Balance at Sep. 30, 2024	$ 2	197,355	(138,083)	59,274
Balance (in shares) at Sep. 30, 2024	21,833,041
Balance at Mar. 31, 2024	$ 2	193,636	(137,852)	55,786
Balance (in shares) at Mar. 31, 2024	21,406,511
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		35		35
Exercise of stock options (in shares)	9,549
Issuance of common stock under stock incentive plans		241		241
Issuance of common stock under stock incentive plans (in shares)	240,623
Stock-based compensation expense		1,862		1,862
Net Income (Loss)			(2,502)	(2,502)
Balance at Jun. 30, 2024	$ 2	195,774	(140,354)	55,422
Balance (in shares) at Jun. 30, 2024	21,656,683
Increase (Decrease) in Stockholders' Equity
Exercise of stock options		44		44
Exercise of stock options (in shares)	11,177
Issuance of common stock under stock incentive plans		5		5
Issuance of common stock under stock incentive plans (in shares)	165,181
Stock-based compensation expense		1,532		1,532
Net Income (Loss)			2,271	2,271
Balance at Sep. 30, 2024	$ 2	$ 197,355	$ (138,083)	$ 59,274
Balance (in shares) at Sep. 30, 2024	21,833,041